Definitions

1. Olmesartan is the seventh angiotensin II receptor blocker (ARB) to become available for the treatment of high blood pressure. (Web site)
2. Olmesartan is a selective AT 1 subtype angiotensin II receptor antagonist. (Web site)
3. Olmesartan is in a group of drugs called angiotensin II receptor antagonists.
4. Olmesartan was distributed to milk at low levels in rats. (Web site)
5. Olmezest (Benicar, Generic Olmesartan) Olmesartan is used for: Treating high blood pressure, alone or with other medicines.

Further Metabolism

1. Olmesartan does not undergo further metabolism and does not interact with cytochrome P450 enzymes.

Age

1. Analysis of covariates showed that age, bodyweight, sex, patient status and renal function were factors influencing the clearance of olmesartan. (Web site)

Gender

1. Analysis of gender, age and race groups demonstrated no differences between olmesartan medoxomil and placebo-treated patients. (Web site)

Human Milk

1. It is not known whether olmesartan is excreted in human milk, but olmesartan is secreted at low concentration in the milk of lactating rats. (Web site)

Similar

1. The effect of hydralazine (5 mg) was similar to that of olmesartan (1 mg) but reached statistical significance only for kidney pentosidine content. (Web site)

Treating High Blood

1. Benicar (Olmesartan) is used for treating high blood pressure, alone or with other medicines.

Absorption

1. Benicar (olmesartan medoxomil), a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.
2. Following the rapid and complete conversion of olmesartan medoxomil to olmesartan during absorption, there is virtually no further metabolism of olmesartan. (Web site)

Patients

1. There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected. (Web site)

Pharmacokinetics

1. Pediatric: The pharmacokinetics of olmesartan have not been investigated in patients <18 years of age. (Web site)
2. Gender: Minor differences were observed in the pharmacokinetics of olmesartan in women compared to men. (Web site)

Angiotensin

1. This removes excess fluid from the body and helps lower blood pressure.Olmesartan is in a group of drugs called angiotensin II receptor antagonists.

Arbs

1. The FDA noted that clinical trials of other ARBs as well as other trials of olmesartan have not revealed an excess risk of cardiovascular mortality. (Web site)

Arb

1. Olmesartan medoxomil is a new angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension. (Web site)

Olmesartan

1. Patient counseling: Tell patients that olmesartan is a new ARB indicated for treatment of high blood pressure. (Web site)
2. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
3. Benicar (olmesartan) is also sold in combination with hydrocholorothiazide as Benicar HCT for the treatment of high blood pressure. (Web site)

Categories

1. Arb
2. Angiotensin
3. Treating High Blood
4. Receptor Antagonists
5. Minor Differences
6. Books about "Olmesartan" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -